首页> 外文期刊>Research communications in molecular pathology and pharmacology >Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ards.
【24h】

Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ards.

机译:脓毒症患者的表面活性蛋白A和D(SP-A,AP-D)水平。

获取原文
获取原文并翻译 | 示例
           

摘要

The levels of surfactant protein-A (SP-A) and surfactant protein-D (SP-D) in the serum of patients with septic acute respiratory distress syndrome (ARDS) were determined. Patients with sepsis without ARDS were examined as controls. The mean serum SP-A level in the former group was 37.6 +/- 16.2 ng/ml and in the latter group was 31.8 +/- 9.6 ng/ml. The difference between the two groups was not statistically significant. The maximum serum SP-D level was 83.0 +/- 33.9 ng/ml in the control group of patients without ARDS, and 476.3 +/- 391.2 ng/ml in the patients with ARDS. The level in the latter population was significantly higher than that in the former population. No significant correlation was observed between the SP-A and SP-D levels. These results suggest that the serum SP-D levels may serve as a good diagnostic indicator of ARDS in patients with sepsis.
机译:测定脓毒症急性呼吸窘迫综合征(ARDS)患者血清中的表面活性剂蛋白A(SP-A)和表面活性剂蛋白D(SP-D)。将无ARDS的败血症患者作为对照。前一组的平均血清SP-A水平为37.6 +/- 16.2 ng / ml,后一组为31.8 +/- 9.6 ng / ml。两组之间的差异无统计学意义。无ARDS的对照组患者的最高血清SP-D水平为83.0 +/- 33.9 ng / ml,而ARDS患者为476.3 +/- 391.2 ng / ml。后一个人口的水平明显高于前一个人口。在SP-A和SP-D水平之间未观察到显着相关性。这些结果表明,血清SP-D水平可以作为败血症患者ARDS的良好诊断指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号